excipient interaction – Pharma.Tips

Troubleshooting Hardness Loss in Bilayer Tablets During Accelerated Testing

Troubleshooting Hardness Loss in Bilayer Tablets During Accelerated Testing Troubleshooting Hardness Loss in Bilayer Tablets During Accelerated Testing Introduction: Bilayer tablets have emerged as a prominent solution in the pharmaceutical…

Investigating Variability in Hardness Retention During Stability Studies

Investigating Variability in Hardness Retention During Stability Studies Investigating Variability in Hardness Retention During Stability Studies Introduction: In the pharmaceutical industry, ensuring the stability of drug products is paramount to…

Troubleshooting Dissolution Variability in Controlled Release Tablets Over Time

Troubleshooting Dissolution Variability in Controlled Release Tablets Over Time Troubleshooting Dissolution Variability in Controlled Release Tablets Over Time Introduction: Controlled release tablets are a cornerstone in modern pharmaceutical therapy, providing…

Ensuring Consistency in Dissolution Profiles for Extended Release Tablets

Ensuring Consistency in Dissolution Profiles for Extended Release Tablets Ensuring Consistency in Dissolution Profiles for Extended Release Tablets Introduction: Extended release (ER) tablets play a pivotal role in modern therapeutic…

Managing API Migration in Multi-API Tablets During Stability Testing

Managing API Migration in Multi-API Tablets During Stability Testing Managing API Migration in Multi-API Tablets During Stability Testing Introduction: In the ever-evolving world of pharmaceuticals, the development of multi-active pharmaceutical…

Challenges in assessing the stability of capsules containing biological APIs.

Challenges in assessing the stability of capsules containing biological APIs. Challenges in assessing the stability of capsules containing biological APIs. Introduction: The pharmaceutical industry is increasingly focusing on the development…

Poor reproducibility in dissolution profiles for lipid-based capsules.

Poor reproducibility in dissolution profiles for lipid-based capsules. Poor reproducibility in dissolution profiles for lipid-based capsules. Introduction: Lipid-based capsules, encompassing both hard and soft gelatin varieties, are critical in the…

Addressing Over-Lubrication in Powder Blends During Compression

Addressing Over-Lubrication in Powder Blends During Compression Addressing Over-Lubrication in Powder Blends During Compression Introduction: In the pharmaceutical industry, the production of high-quality tablets is pivotal. The tablet compression process…

Addressing Over-Lubrication in Powder Mixtures for Blending

Addressing Over-Lubrication in Powder Mixtures for Blending Addressing Over-Lubrication in Powder Mixtures for Blending Introduction: In the pharmaceutical industry, the formulation of solid dosage forms like tablets is a finely…

Addressing API Variability Issues During Quality Assurance Audits

Addressing API Variability Issues During Quality Assurance Audits Addressing API Variability Issues During Quality Assurance Audits Introduction: In the pharmaceutical industry, ensuring the consistency and reliability of Active Pharmaceutical Ingredients…

Addressing Non-Homogeneity in Powder Blends for Multi-API Tablets

Addressing Non-Homogeneity in Powder Blends for Multi-API Tablets Addressing Non-Homogeneity in Powder Blends for Multi-API Tablets Introduction: In the pharmaceutical industry, the production of multi-API (Active Pharmaceutical Ingredient) tablets requires…